Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Masonic Cancer Center, University of Minnesota